Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas

被引:34
|
作者
Schenker, Hannah [1 ]
Buettner-Herold, Maike [2 ]
Fietkau, Rainer [1 ]
Distel, Luitpold V. [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Radiat Oncol, Univ Str 27, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Inst Pathol, Dept Neuropathol, Krankenhausstr 12, D-91054 Erlangen, Germany
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
HNSCC; Cell death; Cell-in-cell; Senescence; Apoptosis; Proliferation; DEATH; CANNIBALISM; ENTOSIS; LEADS;
D O I
10.1186/s13014-016-0746-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study sheds light on cell inactivating processes with focus on the phenomenon of cell-in-cell (CIC). Cell-in-cell describes a cell process where one cell is being engulfed by another non-professional phagocyte. We determined frequency and prognostic impact of CIC structures (CICs) as well as of senescent and apoptotic cells in head and neck squamous cell carcinomas (HNSCC). Methods: These different forms of cell inactivation as well as the proportion of proliferating and tumor cells were assessed in 169 pre-radiochemotherapy biopsies and 32 post-therapy tumor resections by immunohistochemistry of tissue microarrays. Four consecutive cancer sections were stained with antibodies specific for E-cadherin for CIC detection, cleaved caspase-3 for apoptosis, H3K9Me for senescence and Ki67 as a proliferation marker. Positive events were quantified in corresponding tumor areas. Results: CICs were found in 55.5%, senescent cells in 67.1% and apoptotic cells in 93.3% of samples. While no prognostic impact of apoptotic and senescent cells was observed, CICs turned out to significantly influence overallsurvival (p = 0.016) with a lack of CICs being prognostically beneficial. There was no correlation between CICs and apoptosis and 98.9% of CICs were negative for cleaved caspase-3. Conclusion: CIC formation is a frequent event in HNSCC and a superior predictive marker compared to senescence and apoptosis. Independence of CIC and apoptosis and the adverse prognosis associated with numerous CICs lead to the assumption that CICs might take up necrotic rather than apoptotic cells preventing an adequate antitumoral immune response that would otherwise be initiated by necrotic cells through damage-associated molecular pattern molecules.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cell-in-cell structures are more potent predictors of outcome than senescence or apoptosis in head and neck squamous cell carcinomas
    Hannah Schenker
    Maike Büttner-Herold
    Rainer Fietkau
    Luitpold V. Distel
    Radiation Oncology, 12
  • [2] Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas
    Brust, Lukas A.
    Vorschel, Meike
    Koerner, Sandrina
    Knebel, Moritz
    Kuehn, Jan Philipp
    Wemmert, Silke
    Smola, Sigrun
    Wagner, Mathias
    Schick, Bernhard
    Linxweiler, Maximilian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
  • [3] CLINICAL OUTCOME OF 205 HEAD AND NECK SQUAMOUS CELL CARCINOMAS
    Riberti, C.
    Carinci, F.
    Zollino, I.
    Candotto, V.
    Moretti, L.
    Candiani, M.
    Brunelli, G.
    Monguzzi, R.
    EUROPEAN JOURNAL OF INFLAMMATION, 2011, 9 (03) : 85 - 88
  • [4] Squamous cell carcinomas of the head and neck
    Sanderson, RJ
    Ironside, JAD
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7368): : 822 - 827
  • [5] Squamous cell carcinomas of the head and neck
    Demard, F.
    Schneider, M.
    ONCOLOGIE, 2009, 11 (03) : 115 - 115
  • [6] Cell-in-Cell Structures have a higher prognostic Relevance in Head-Neck-Tumors than Apoptose
    Schenker, H. M.
    Buettner, M.
    Fietkau, R.
    Distel, L., V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S43 - S44
  • [7] Management and outcome of head and neck squamous cell carcinomas in obese patients
    Deneuve, S.
    Tan, H. K.
    Eghiaian, A.
    Temam, S.
    ORAL ONCOLOGY, 2011, 47 (07) : 631 - 635
  • [8] Cetuximab in squamous cell head and neck carcinomas
    Gebbia, V.
    Giuliani, F.
    Valori, V. M.
    Agueli, R.
    Coiucci, G.
    Maiello, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 5 - 7
  • [9] Basaloid squamous cell carcinomas of the head and neck
    Thariat, J.
    Badoual, C.
    Faure, C.
    de Mones, E.
    Butori, C.
    Santini, J.
    Poissonnet, G.
    Maingon, P.
    Faivre, S.
    Klijanienko, J.
    Saint-Guily, J. Lacau
    Righini, C. A.
    BULLETIN DU CANCER, 2009, 96 (10) : 989 - 1004
  • [10] Predictors of Outcome With Cetuximab and Paclitaxel for Head and Neck Squamous Cell Carcinoma
    Ferreira, Bruna Pellini
    Redman, Mary
    Baker, Kelsey K.
    Martins, Renato
    Eaton, Keith D.
    Chow, Laura Quan Man
    Baik, Christina S.
    Goulart, Bernardo
    Lee, Sylvia Mina
    Santana-Davila, Rafael
    Rodriguez, Cristina P.
    LARYNGOSCOPE, 2017, 127 (07): : 1583 - 1588